Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-27
DOI
10.1007/s00198-021-05925-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study
- (2020) A. Tominaga et al. OSTEOPOROSIS INTERNATIONAL
- Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension
- (2019) Akimitsu Miyauchi et al. Archives of Osteoporosis
- Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition)
- (2019) Yoshiki Nishizawa et al. CLINICA CHIMICA ACTA
- Romosozumab for the treatment of osteoporosis
- (2017) Leonardo Bandeira et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study
- (2016) David W. Dempster et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inter-method variability in bone alkaline phosphatase measurement: Clinical impact on the management of dialysis patients
- (2014) Etienne Cavalier et al. CLINICAL BIOCHEMISTRY
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cohort Profile: Research on Osteoarthritis/Osteoporosis Against Disability study
- (2009) N. Yoshimura et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study
- (2009) Noriko Yoshimura et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid
- (2009) Stergios A. Polyzos et al. SUPPORTIVE CARE IN CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now